Maternal–fetal transfer rates of PCBs, OCPs, PBDEs, and dioxin-like compounds predicted through quantitative structure–activity relationship modeling

Environmental Science and Pollution Research

Volumn 25, Issue 8, 2018, Pages 7212-7222

  Eguchi, Akifumi ^a   Hanazato, Masamichi ^a   Suzuki, Norimichi ^a   Matsuno, Yoshiharu ^a   Todaka, Emiko ^a   Mori, Chisato ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Dioxins; Maternal transfer rate; POPs; QSAR

Indexed keywords

BIOCHEMISTRY; CHILD HEALTH; DIOXIN; MATERNAL EFFECT; NUMERICAL MODEL; PBDE; PCB; PERSISTENT ORGANIC POLLUTANT; PREDICTION; QUANTITATIVE ANALYSIS;

CHLORINATED HYDROCARBON; DIOXIN; DIPHENYL ETHER DERIVATIVE; PESTICIDE; POLYCHLORINATED BIPHENYL;

CHEMISTRY; FEMALE; FETUS; HUMAN; LEAST SQUARE ANALYSIS; PREGNANCY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL;

DIOXINS; FEMALE; FETUS; HALOGENATED DIPHENYL ETHERS; HUMANS; HYDROCARBONS, CHLORINATED; LEAST-SQUARES ANALYSIS; LINEAR MODELS; PESTICIDES; POLYCHLORINATED BIPHENYLS; PREGNANCY; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84944711288     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-015-5436-0     Document Type: Article

References (44)

1. Akaike H (1998) Information theory and an extension of the maximum likelihood principle. In: Parzen E, Tanabe K, Kitagawa G (eds) Selected papers of Hirotugu Akaike. Springer, New York
2. Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730–741
3. Audus KL (1999) Controlling drug delivery across the placenta. Eur J Pharm Sci 8:161–165
4. Aylward LL, Hays SM, Kirman CR, Marchitti SA, Kenneke JF, English C, Mattison DR, Becker RA (2014) Relationships of chemical concentrations in maternal and cord blood: a review of available data. J Toxicol Environ Health Part B 17:175–203
5. Bourget P, Roulot C, Fernandez H (1995) Models for placental-transfer studies of drugs. Clin Pharmacokinet 28:161–180
6. Breiman L (2001) Random forests. Mach Learn 45:5–32
7. Brouwer A, Ahlborg UG, Vandenberg M, Birnbaum LS, Boersma ER, Bosveld B, Denison MS, Gray LE, Hagmar L, Holene E, Huisman M, Jacobson SW, Jacobson JL, Koopmanesseboom C, Koppe JG, Kulig BM, Morse DC, Muckle G, Peterson RE, Sauer PJJ, Seegal RF, Smitsvanprooije AE, Touwen BCL, Weisglaskuperus N, Winneke G (1995) Functional aspects of developmental toxicity of polyhalogenated aromatic hydrocarbons in experimental animals and human infants. Eur J Pharmacol-Environ 293:1–40
8. Deeley RG, Westlake C, Cole SPC (2006) Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86:849–899
9. EPA (2012) U. Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.11. United States Environmental Protection Agency, Washington, DC, USA
10. Fukata H, Omori M, Osada H, Todaka E, Mori C (2005) Necessity to measure PCBs and organochlorine pesticide concentrations in human umbilical cords for fetal exposure assessment. Environ Health Perspect 113:297–303
11. Giaginis C, Zira A, Theocharis S, Tsantili-Kakoulidou A (2009) Application of quantitative structure-activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approach. J Appl Toxicol 29:724–733
12. Grandjean P, Landrigan PJ (2006) Developmental neurotoxicity of industrial chemicals. Lancet 368:2167–2178
13. Grandjean P, Landrigan PJ (2014) Neurobehavioural effects of developmental toxicity. Lancet Neurol 13:330–338
14. Hewitt M, Madden JC, Rowe PH, Cronin MTD (2007) Structure-based modelling in reproductive toxicology: (Q)SARs for the placental barrier. SAR QSAR Environ Res 18:57–76
15. Jiang YZ, Wang K, Fang R, Zheng J (2010) Expression of aryl hydrocarbon receptor in human placentas and fetal tissues. J Histochem Cytochem 58:679–685
16. Jotaki T, Fukata H, Mori C (2011) Confirmation of polychlorinated biphenyl (PCB) distribution in the blood and verification of simple quantitative method for PCBs based on specific congeners. Chemosphere 82:107–113
17. Kawashiro Y, Fukata H, Inoue MO, Kubonoya K, Jotaki T, Takigami H, Sakai SI, Mori C (2008) Perinatal exposure to brominated flame retardants and polychlorinated biphenyls in japan. Endocr J 55:1071–1084
18. Koppe JG, Olie K, Vanwijnen J (1992) Placental transport of dioxins from mother to fetus. 2. PCBS, dioxins and furans and vitamin-K metabolism. Dev Pharmacol Ther 18:9–13
19. Kovdienko NA, Polishchuk PG, Muratov EN, Artemenko AG, Kuz'min VE, Gorb L, Hill F, Leszczynski J (2010) Application of random forest and multiple linear regression techniques to QSPR prediction of an aqueous solubility for military compounds. Mol Inf 29:394–406
20. Kuhn M (2008) Building predictive models in R using the caret package. J Stat Softw 28:1–26
21. Lancz K, Murínová Ľ, Patayová H, Drobná B, Wimmerová S, Šovčíková E, Kováč J, Farkašová D, Hertz-Picciotto I, Jusko TA, Trnovec T (2015) Ratio of cord to maternal serum PCB concentrations in relation to their congener-specific physicochemical properties. Int J Hyg Environ Health 218:91–98
22. Lewis DFV, Modi S, Dickins M (2002) Structure-activity relationship for human cytochrome P450 substrates and inhibitors. Drug Metab Rev 34:69–82
23. Mably TA, Bjerke DL, Moore RW, Gendron-Fitzpatrick A, Peterson RE (1992) In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin: 3 effects on spermatogenesis and reproductive capability. Toxicol Appl Pharmacol 114:118–126
24. Manchester DK, Gordon SK, Golas CL, Roberts EA, Okey AB (1987) Ah receptor in human placenta—stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-para-dioxin, 3-methylcholanthrene, and benzo(a)pyrene. Cancer Res 47:4861–4868
25. Marchesini GR, Meimaridou A, Haasnoot W, Meulenberg E, Albertus F, Mizuguchi M, Takeuchi M, Irth H, Murk AJ (2008) Biosensor discovery of thyroxine transport disrupting chemicals. Toxicol Appl Pharmacol 232:150–160
26. Meylan WM, Howard PH (2000) Estimating log P with atom/fragments and water solubility with log P. Perspect Drug Discov 19:67–84
27. Monteiro CJP, Pereira MM, Pinto SMA, Simoes AVC, Sa GFF, Arnaut LG, Formosinho SJ, Simoes S, Wyatt MF (2008) Synthesis of amphiphilic sulfonamide halogenated porphyrins: MALDI-TOFMS characterization and evaluation of 1-octanol/water partition coefficients. Tetrahedron 64:5132–5138
28. Mori C, Nakamura N, Todaka E, Fujisaki T, Matsuno Y, Nakaoka H, Hanazato M (2014) Correlation between human maternal-fetal placental transfer and molecular weight of PCB and dioxin congeners/isomers. Chemosphere 114:262–267
29. Myllynen P, Pasanen M, Pelkonen O (2005) Human placenta: a human organ for developmental toxicology research and biomonitoring. Placenta 26:361–371
30. Myllynen P, Immonen E, Kummu M, Vahakangas K (2009) Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab 5:1483–1499
31. Needham LL, Grandjean P, Heinzow B, Jorgensen PJ, Nielsen F, Patterson DG, Sjodin A, Turner WE, Weihe P (2011) Partition of environmental chemicals between maternal and fetal blood and tissues. Environ Sci Technol 45:1121–1126
32. Pasanen M (1999) The expression and regulation of drug metabolism in human placenta. Adv Drug Deliv Rev 38:81–97
33. Qi Y (2012) Random forest for bioinformatics. In: Zhang C, Ma Y (eds) Ensemble machine learning. Springer, US
34. Reynolds F (1998) Drug transfer across the term placenta: a review. Placenta 19(Supplement 2):239–255
35. Rucker C, Rucker G, Meringer M (2007) y-Randomization and its variants in QSPR/QSAR. J Chem Inf Model 47:2345–2357
36. Sakurai K, Todaka E, Saito Y, Mori C (2004) Pilot study to reduce dioxins in the human body. Intern Med 43:792–795
37. Stewart JJP (2007) Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements. J Mol Model 13:1173–1213
38. Stewart JJP, MOPAC 2009 Version 9.03CS. Stewart Computational Chemistry. HTTP://OpenMOPAC.net: 2008
39. Tropsha A (2010) Best practices for QSAR model development, validation, and exploitation. Mol Inf 29:476–488
40. Ucan-Marin F, Arukwe A, Mortensen AS, Gabrielsen GW, Letcher RJ (2010) Recombinant albumin and transthyretin transport proteins from two gull species and human: chlorinated and brominated contaminant binding and thyroid hormones. Environ Sci Technol 44:497–504
41. Vahakangas K, Myllynen P (2009) Drug transporters in the human blood-placental barrier. Br J Pharmacol 158:665–678
42. Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws L, Rose M, Safe S, Schrenk D, Tohyama C, Tritscher A, Tuomisto J, Tysklind M, Walker N, Peterson RE (2006) The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93:223–241
43. Wold S, Sjostrom M, Eriksson L (2001) PLS-regression: a basic tool of chemometrics. Chemom Intell Lab 58:109–130
44. Zhang SX, Golbraikh A, Oloff S, Kohn H, Tropsha A (2006) A novel automated lazy learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models. J Chem Inf Model 46:1984–1995